Precigen has won approval in the US for a first-in-class immunotherapy for recurrent respiratory papillomatosis (RRP), a rare ...

The Baloch Liberation Army (BLA) has rejected the United States' decision to classify its unit, the Majeed Brigade, as a ...

The Baloch Liberation Army (BLA) rejected the US designation of its Majeed Brigade as a terrorist group, calling it detached ...

After securing a major diplomatic win in Washington, Pakistan is expected to bring before the United Nations Security Council ...

Read here for more on ClearPoint Neuro (CLPT) stock's Q2 performance, key catalysts like GLP services, and future growth ...

WALTHAM, Mass., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced financial results for the quarter ended June 30, 2025, and provided recent business highlights.

Presented positive results from the phase 3 randomized, placebo-controlled clinical trial of CAN-2409 (aglatimagene besadenovec) in localized prostate cancer, during an oral presentation at the 2025 ...

GAAP EPS loss of $0.41 in Q2 2025 beat analyst expectations for a larger loss of $0.48 per share. R&D expenses (GAAP) rose 19% to $23.4 million in Q2 2025 compared to Q2 2024, primarily due to higher ...

Larimar Therapeutics ( (LRMR) ) has issued an announcement. On August 14, 2025, Larimar Therapeutics reported its second quarter 2025 financial results, highlighting significant progress in its ...

Explore Inovio Pharmaceuticals' Q2 2025 earnings call highlights, including progress on INO-3107, regulatory milestones, financial updates, and ...